复方苦参注射液联合化疗治疗晚期肺腺癌临床疗效观察

    Clinical efficacy of Fufangkushen injection combined with chemotherapy in the treatment of advanced lung adenocarcinoma

    • 摘要: 目的:观察复方苦参注射液联合化疗治疗晚期肺腺癌患者的疗效。方法:87例晚期肺腺癌患者随机分为复方苦参注射液联合化疗组(观察组)44例和单纯化疗组(对照组)43例。临床观察终点指标包括有效率、至病情进展时间和生活质量。结果:观察组总有效率36.4%,对照组总有效率30.2%,2组疗效差异无统计学意义(P>0.05);观察组至病情进展时间与对照组差异无统计学意义(P>0.05)。观察组生活质量评分显著优于对照组(P<0.01)。观察组不良反应发生率低于对照组(P<0.05~P<0.01)。结论:复方苦参注射液无法提高治疗反应和延长生存期,但能改善患者的生活质量,并能减轻化疗的不良反应。

       

      Abstract: Objective:To investigate the clinical efficacy of Fufangkushen injection combined with chemotherapy in the treatment of advanced lung adenocarcinoma.Methods:Eighty-seven patients with advanced lung adenocarcinoma were randomly divided into the Fufangkushen injection combined with chemotherapy group(observation group, 44 cases) and chemotherapy alone group(control group, 43 cases).The effective rate, progression-free survival and quality of life in two groups were observed.Results:The total effective rates in observation group and control group were 36.4% and 30.2%, respectively, the difference of which was not statistically significant(P>0.05).The difference of the progression-free survival between two groups was not statistically significant(P>0.05).The score of quality of life in observation group was better than that in control group(P<0.01).The incidence of adverse reaction in observation group was lower than that in control group(P<0.05 to P<0.01).Conclusions:Fufangkushen injection combined with chemotherapy treatment can not improve treatment response and prolong survival time, but which can improve the quality of life and alleviate the adverse reaction of chemotherapy.

       

    /

    返回文章
    返回